Summit Therapeutics plc Block Listing Six Month Review
03 10월 2019 - 3:00PM
UK Regulatory
TIDMSUMM
BLOCK LISTING SIX MONTHLY RETURN
(Note: Italicised terms have the same meaning as given in the Listing
Rules.)
Date: 3 October 2019
Name of applicant: Summit Therapeutics plc
-------------------------------------------------------------- ------------------------------
Name of scheme: 2005 EMI Scheme
-------------------------------------------------------------- ------------------------------
Period of return: From: 31 Mar 2019 To: 30 Sept 2019
------------------------------------- ----------------------- ----------- --- ------------
Balance of unallotted securities under scheme(s) from
previous return: 776,756
-------------------------------------------------------------- ------------------------------
Plus: The amount by which the block scheme(s) has
been increased since the date of the last return (if
any increase has been applied for): Zero
-------------------------------------------------------------- ------------------------------
Less: Number of securities issued/allotted under scheme(s)
during period (see LR3.5.7G): Zero
-------------------------------------------------------------- ------------------------------
Equals: Balance under scheme(s) not yet issued/allotted
at end of period: 476,756
-------------------------------------------------------------- ------------------------------
Name of applicant: Summit Therapeutics plc
-------------------------------------------------------------- --------------------------------
Name of scheme: 2016 Long Term Incentive Plan
-------------------------------------------------------------- --------------------------------
Period of return: From: 31 Mar 2019 To: 30 Sep 2019
------------------------------------ ------------------------ ------------ ---- ------------
Balance of unallotted securities under scheme(s) from
previous return: 4,196,863
-------------------------------------------------------------- --------------------------------
Plus: The amount by which the block scheme(s) has
been increased since the date of the last return (if
any increase has been applied for): Zero
-------------------------------------------------------------- --------------------------------
Less: Number of securities issued/allotted under scheme(s)
during period (see LR3.5.7G): Zero
-------------------------------------------------------------- --------------------------------
Equals: Balance under scheme(s) not yet issued/allotted
at end of period: 4,196,863
-------------------------------------------------------------- --------------------------------
Name of contact: Richard Pye
----------------------------- ------------------
Telephone number of contact: +44 (0)1235 443951
----------------------------- ------------------
This figure has been reduced since the last block list review to reflect
the number of share options that remain in existence under the 2005 EMI
Scheme. This change is due share options issued under the 2005 EMI
Scheme having lapsed due to employees leaving the Company. No new share
options will be issued under the 2005 EMI Scheme.
(END) Dow Jones Newswires
October 03, 2019 02:00 ET (06:00 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Summit Therapeutics (LSE:SUMM)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025
Summit Therapeutics (LSE:SUMM)
과거 데이터 주식 차트
부터 1월(1) 2024 으로 1월(1) 2025
Summit Therapeutics Plc (런던증권거래소)의 실시간 뉴스: 최근 기사 0
More Summit Therapeutics Plc News Articles